pharmocodynamics and mechanisms of drug action

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/39

encourage image

There's no tags or description

Looks like no tags are added yet.

40 Terms

1
New cards

Dose-Response Curve

A graph showing that for most drugs, the magnitude of pharmacologic response is proportionately related to the (log of) drug concentration at the tissue (receptor) site — "as you give more drug, you get more response"

2
New cards

Phase 1 of Dose-Response Curve

No response observed at low drug concentrations

3
New cards

Phase 2 of Dose-Response Curve

Linear response with desired effect; ideal dosing regimen results in plasma drug concentrations (PDC) that fall within this therapeutic range

4
New cards

Phase 3 of Dose-Response Curve

No increased response seen despite higher doses; toxic effects become possible

5
New cards

ED50

Effective Dose in 50% of a population

6
New cards

TD50

Toxic Dose in 50% of a population

7
New cards

LD50

Lethal Dose in 50% of a population

8
New cards

Therapeutic Index

The ratio of TD50 to ED50 (TD50/ED50); provides an indication of drug safety — the larger (wider) the index, the safer the drug

9
New cards

Wide Therapeutic Index

A large separation between the effective dose curve and the toxic dose curve, indicating a safer drug

10
New cards

Narrow Therapeutic Index

A small separation between the effective dose curve and the toxic dose curve, indicating a less safe drug requiring careful dosing

11
New cards

Pharmacodynamics (mechanism)

How drugs produce effects in the body via biochemical/physiologic changes; the drug binds to a receptor, causing a change in physical property of the cell or chemical/metabolic changes — drugs do NOT create new cell effects/actions

12
New cards

Drug Receptor

A protein on or within the cell surface/cytoplasm that a ligand binds to in order to produce an effect

13
New cards

Ligand

Something that binds a receptor; can be an endogenous signal molecule or a drug

14
New cards

Ion Channel Receptor

A ligand-gated receptor type that opens or closes an ion channel upon agonist binding, leading to activation of conductance

15
New cards

GPCR (G-Protein Coupled Receptor)

A receptor type that, upon agonist binding, activates a G-protein, generating a second messenger and activating cell signaling

16
New cards

Enzyme-Linked Receptor (Receptor Tyrosine Kinase)

A receptor type where agonist binding causes phosphorylation of tyrosines on key signaling molecules, activating cell signaling (e.g., Tyrosine Kinase)

17
New cards

Intracellular Hormone Receptor

A receptor type where the agonist is transported to the nucleus, activating transcription and translation

18
New cards

Receptor Upregulation/Downregulation

An adaptive mechanism where receptor number or sensitivity changes, which may affect clinical response, especially with chronic drug exposure

19
New cards

Tachyphylaxis

"Acute tolerance" — a rapidly decreasing response to a drug after only a few doses

20
New cards

Tolerance

A decreasing response to repeated constant doses of a drug; may be pharmacokinetic or pharmacodynamic in nature (terms often used interchangeably); accounts for why a drug may stop working over time

21
New cards

Affinity

The force of attraction between a drug and its receptor; higher affinity drugs are harder to displace from the receptor

22
New cards

Selectivity

The specificity of a drug for its target receptor binding (e.g., alpha 1/2, beta 1/2, dopamine 1/2 receptors); important because it produces stronger effects on the target receptor and fewer side effects on unwanted receptors

23
New cards

Potency

A comparative term describing the concentration of different drugs necessary to induce the same magnitude of response; a more potent drug is NOT necessarily a better drug — potency and clinical superiority are different concepts

24
New cards

EC50

The concentration of a drug required to produce 50% of its maximal response; used to compare potency between drugs (lower EC50 = higher potency)

25
New cards

Efficacy (Intrinsic Activity)

The ability of a drug to produce a response upon binding a receptor; a complex relationship involving drug concentration, receptor activation, and cellular response

26
New cards

Agonist

A drug that binds to a receptor and activates it, causing a response; based on occupation theory, where the magnitude of response is proportional to the number of receptors occupied

27
New cards

Full Agonist

A drug that binds to a receptor and produces the maximal possible biological response

28
New cards

Partial Agonist

A drug that binds to and activates a receptor but only produces a partial response; maximal response is not observed (lower efficacy) even at full receptor occupancy

29
New cards

Antagonist

A drug that interacts selectively with receptors but lacks intrinsic efficacy; it blocks or reduces the action of an agonist at the receptor, producing no effect of its own

30
New cards

Inverse Agonist

A drug that binds a receptor with constitutive (baseline) activity and produces a "negative" response, reducing activity below the receptor's basal level (e.g., some H2-receptor drugs)

31
New cards

Neutral Antagonist

A drug that binds a receptor without altering its baseline (constitutive) activity, simply blocking other ligands from binding

32
New cards

Competitive Antagonist

Binds weakly (reversibly) to the same receptor site as the agonist; the inhibitory effect CAN be reversed by increasing the dose of the agonist, since both compete for the same binding site

33
New cards

Noncompetitive Antagonist

Binds strongly to the same receptor site (irreversibly) or allosterically at a different site; the inhibitory effect CANNOT be reversed by increasing the dose of the agonist

34
New cards

Reversible Antagonist Binding

Binding via weak bonds (H-bonds, van der Waals forces) that can be displaced when agonist concentration increases; results in decreased potency but same maximal efficacy

35
New cards

Irreversible Antagonist Binding

Binding via strong bonds (e.g., covalent bonds) that cannot be broken/displaced even with more agonist; results in decreased maximal efficacy, even at higher agonist doses

36
New cards

Chemical Antagonism

A type of antagonism involving direct chemical interaction between two drugs (e.g., a weak acid and a weak base neutralizing each other)

37
New cards

Physiologic Antagonism

Two drugs act in the same physiologic system but on different receptors or pathways, producing opposing effects

38
New cards

Pharmacokinetic Antagonism

One drug alters the response to another drug through changes in its disposition (absorption, distribution, metabolism, or excretion)

39
New cards

Drug Characteristics Affecting Receptor Concentration

Factors including molecular weight (smaller = more transfer), lipid solubility (higher = more transfer), pKa (unionized = more transfer), protein binding (lower = more transfer), and concentration gradient (higher = more transfer)

40
New cards

Requirements for Pharmacodynamic Effect

Drugs must reach the receptor to have an effect, which requires good pharmacokinetics and certain physicochemical properties of the drug